Susbstance Abuse and Mental Health Services Administration (SAMSHA). (2009). Results from the 2008 National Survey on Drug Use and Health: National findings. Rockville, MD: SAMSHA, Office of Applied Studies. NSDUH Series H-36, HHS Publication No. SMA 09-4434.
Warren, K. R., Hewitt, B. G., & Thomas, J. D. (2011). Fetal alcohol spectrum disorders: Research challenges and oppourtunities. Alcohol Research & Health, 34(1), 4–14.
Bertrand, J., Floyd, R. L., Weber, M. K., O’Connor, M., Riley, E. P., Johnson, K. A., et al. (2004). Fetal alcohol syndrome: Guidelines for referral and diagnosis. Atlanta, GA: Centers for Disease Control and Prevention.
Addis, A., Moretti, M. E., Ahmed Syed, F., Einarson, T. R., & Koren, G. (2001). Fetal effects of cocaine: An updated meta-analysis. Reproductive Toxicology,
Gouin, K., Murphy, K., & Shah, P. S. (2011). Effects of cocaine use during pregnancy on low birthweight and preterm birth: Systematic review and metaanalyses. American Journal of Obstetrics and Gynecology,
Savitz, D. A., & Murnane, P. (2010). Behavioral influences on preterm birth: A review. Epidemiology,
Lipshultz, S. E., Frassica, J. J., & Orav, E. J. (1991). Cardiovascular abnormalities in infants prenatally exposed to cocaine. Journal of Pediatrics,
Ladhani, N. N., Shah, P. S., & Murphy, K. E. (2011). Prenatal amphetamine exposure and birth outcomes: A systematic review and metaanalysis. American Journal of Obstetrics and Gynecology,
Derauf, C., Kekatpure, M., Neyzi, N., Lester, B., & Kosofsky, B. (2009). Neuroimaging of children following prenatal drug exposure. Seminars in Cell & Developmental Biology,
Roussotte, F., Soderberg, L., & Sowell, E. (2010). Structural, metabolic, and functional brain abnormalities as a result of prenatal exposure to drugs of abuse: Evidence from neuroimaging. Neuropsychology Review,
American Academy of Pediatrics Committee on Drugs. (1998). Neonatal drug withdrawal. Pediatrics,
Robbins, J. M., Bird, T. M., Tilford, J. M., Reading, J. A., Cleves, M. A., Aitken, M. E., et al. (2006). Reduction in newborns with discharge coding of in utero alcohol effects in the United States, 1993 to 2002. Archives of Pediatrics and Adolescent Medicine,
National Center for Health Statistics. (2011). Healthy people 2010 final review
. Hyattsville, MD: Centers for Disease Control and Prevention (CDC), National Center for Health Statistics [cited November 29, 2011]. Available from: http://www.cdc.gov/nchs/data/hpdata2010/hp2010_final_review.pdf
Dicker, M., & Leighton, E. A. (1994). Trends in the US prevalence of drug-using parturient women and drug-affected newborns, 1979 through 1990. American Journal of Public Health,
O’Donnell, M., Nassar, N., Leonard, H., Hagan, R., Mathews, R., Patterson, Y., et al. (2009). Increasing prevalence of neonatal withdrawal syndrome: Population study of maternal factors and child protection involvement. Pediatrics,
Healthcare Cost and Utilization Project (HCUP). (2008). Introduction to the HCUP Nationwide Inaptient Sample (NIS)
. Rockville, MD: US Department of Health and Human Services, Agency for Healthcare Research and Quality [cited September 20, 2010]. Available from: http://www.hcup-us.ahrq.gov/db/nation/nis/NIS_Introduction_2008.jsp
Centers for Medicare and Medicaid Services, National Center for Health Statistics. (2010). ICD
-CM official guidelines for coding and reporting
. Effective October 1, 2010 [cited December 1, 2010]. Available from: http://www.cdc.gov/nchs/data/icd9/icdguide10.pdf
Healthcare Cost and Utilization Project (HCUP). (2011). Cost
-charge ratio files
. Rockville, MD: US Department of Health and Human Services, Agency for Healthcare Research and Quality [cited April 17, 2012]. Available from: http://www.hcup-us.ahrq.gov/db/state/costtocharge.jsp
US Department of Labor Bureau of Labor Statistics. (2012). Consumer price index. Chained consumer price index for all urban consumers (C
-U), US All Items. Series ID: SUUR0000SA0
. Washington, DC: US Department of Labor [cited April 25, 2012]. Available from: http://data.bls.gov/cgi-bin/surveymost?su
Healthcare Cost and Utilization Project (HCUP). (2011). NIS description of data elements
. Rockville, MD: US Department of Health and Human Services, Agency for Healthcare Research and Quality [cited March 29, 2011]. Available from: http://www.hcup-us.ahrq.gov/db/nation/nis/nisdde.jsp
Cox, S., Posner, S. F., Kourtis, A. P., & Jamieson, D. J. (2008). Hospitalizations with amphetamine abuse among pregnant women. Obstetrics and Gynecology,
(2 Pt 1), 341–347.PubMedCrossRef
Terplan, M., Smith, E. J., Kozloski, M. J., & Pollack, H. A. (2009). Methamphetamine use among pregnant women. Obstetrics and Gynecology,
Cox, S., Johnson, C. H., Meikle, S., Jamieson, D. J., & Posner, S. F. (2007). Trends in rates of hospitalization with a diagnosis of substance abuse among reproductive-age women, 1998 to 2003. Womens Health Issues,
National Drug Intelligence Center. (2011). National drug threat assessment 2011
. Washington, DC: US Department of Justice, National Drug Intelligence Center [cited September 20, 2011]. Available from: http://www.justice.gov/ndic/pubs44/44849/44849p.pdf
Substance Abuse and Mental Health Services Administration (SAMSHA). (2011). Results from the 2010 National Survey on Drug Use and Health: Summary of national findings. Rockville, MD: SAMSHA, Office of Applied Studies. NSDUH Series H-41, HHS Publication No. SMA 11-4658.
Compton, W. M., & Volkow, N. D. (2006). Major increases in opioid analgesic abuse in the United States: Concerns and strategies. Drug and Alcohol Dependence,
Substance Abuse and Mental Health Services Administration (SAMSHA). (2010) Treatment episode data set (TEDS): 1998–2008. National Admissions to Substance Abuse Treatment Services. Rockville, MD: SAMSHA, Office of Applied Studies. DASIS Series: S-50, HHS Publication No. SMA 09-4471.
Centers for Disease Control and Prevention. (2010). Emergency department visits involving nonmedical use of selected prescription drugs—United States, 2004–2008. MMWR,
Cox, S., Kuo, C., Jamieson, D. J., Kourtis, A. P., McPheeters, M. L., Meikle, S. F., et al. (2011). Poisoning hospitalisations among reproductive-aged women in the USA, 1998–2006. Injury Prevention,
Coben, J. H., Davis, S. M., Furbee, P. M., Sikora, R. D., Tillotson, R. D., & Bossarte, R. M. (2010). Hospitalizations for poisoning by prescription opioids, sedatives, and tranquilizers. American Journal of Preventive Medicine,
Bohnert, A. S., Fudalej, S., & Ilgen, M. A. (2010). Increasing poisoning mortality rates in the United States, 1999–2006. Public Health Reports,
Paulozzi, L. J., & Annest, J. L. (2007). US data show sharply rising drug-induced death rates. Injury Prevention,
Paulozzi, L. J., & Centers for Disease Control and Prevention (CDC). (2011). Drug-induced deaths: United States, 2003–2007. MMWR Surveillance Summaries, 60(suppl), 60–61.
Harder, V. S., & Chilcoat, H. D. (2007). Cocaine use and educational achievement: understanding a changing association over the past 2 decades. American Journal of Public Health,
Substance Abuse and Mental Health Services Administration (SAMSHA). (2009). Results from the 2008 National Survey on Drug Use and Health: Detailed tables
. Rockville, MD: SAMSHA, Office of Applied Studies [cited August 2, 2011]. Available from: http://oas.samhsa.gov/NSDUH/2K8NSDUH/tabs/INDEX.PDF
Henderson, J., Gray, R., & Brocklehurst, P. (2007). Systematic review of effects of low-moderate prenatal alcohol exposure on pregnancy outcome. BJOG,
Ventura, S. J., Martin, J. A., Curtin, S. C., Menacker, F., & Hamilton, B. E. (2001). Births: Final data for 1999. Hyattsville, MD: National Center for Health Statistics.
Martin, J. A., Hamilton, B. E., Sutton, P. D., Ventura, S. J., Mathews, T. J., & Osterman, M. J. K. (2010). Births: Final data for 2008. Hyattsville, MD: National Center for Health Statistics.
Havens, J. R., Simmons, L. A., Shannon, L. M., & Hansen, W. F. (2009). Factors associated with substance use during pregnancy: Results from a national sample. Drug and Alcohol Dependence,
Ethen, M. K., Ramadhani, T. A., Scheuerle, A. E., Canfield, M. A., Wyszynski, D. F., Druschel, C. M., et al. (2009). Alcohol consumption by women before and during pregnancy. Maternal and Child Health Journal,
Diekman, S. T., Floyd, R. L., Découflé, P., Schulkin, J., Ebrahim, S. H., & Sokol, R. J. (2000). A survey of obstetrician-gynecologists on their patients’ alcohol use during pregnancy. Obstetrics and Gynecology,
Anderson, B. L., Dang, E. P., Floyd, R. L., Sokol, R., Mahoney, J., & Schulkin, J. (2010). Knowledge, opinions, and practice patterns of obstetrician-gynecologists regarding their patients’ use of alcohol. Journal of Addiction Medicine,
Roberts, S. C., & Nuru-Jeter, A. (2011). Universal alcohol/drug screening in prenatal care: A strategy for reducing racial disparities? Questioning the assumptions. Maternal and Child Health Journal,
Ellsworth, M. A., Stevens, T. P., & D’Angio, C. T. (2010). Infant race affects application of clinical guidelines when screening for drugs of abuse in newborns. Pediatrics,
Gavin, N. I., Adams, E. K., Hartmann, K. E., Benedict, M. B., & Chireau, M. (2004). Racial and ethnic disparities in the use of pregnancy-related health care among Medicaid pregnant women. Maternal and Child Health Journal,
Fussell, H. E., Rieckmann, T. R., & Quick, M. B. (2011). Medicaid reimbursement for screening and brief intervention for substance misuse. Psychiatric Services (Washington, D. C.),
Lester, B. M., Andreozzi, L., & Appiah, L. (2004). Substance use during pregnancy: Time for policy to catch up with research. Harm Reduction Journal,
Guttmacher Institute. (2011). State policies in brief
—substance abuse during pregnancy
(as of November 1, 2011). [cited November 23, 2011]. Available from: http://www.guttmacher.org/statecenter/spibs/spib_SADP.pdf
Babor, T. F., McRee, B. G., Kassebaum, P. A., Grimaldi, P. L., Ahmed, K., & Bray, J. (2007). Screening, brief intervention, and referral to treatment (SBIRT): Toward a public health approach to the management of substance abuse. Substance Abuse,
Madras, B. K., Compton, W. M., Avula, D., Stegbauer, T., Stein, J. B., & Clark, H. W. (2009). Screening, brief interventions, referral to treatment (SBIRT) for illicit drug and alcohol use at multiple healthcare sites: Comparison at intake and 6 months later. Drug and Alcohol Dependence,
ACOG Committee Opinion No. 422 (2008) At-risk drinking and illicit drug use: Ethical issues in obstetric and gynecologic practice. Obstetrics and Gynecology, 112(6), 1449–1460.